CME Group Inc. (NASDAQ:CME) Shares Sold by Elo Mutual Pension Insurance Co

Elo Mutual Pension Insurance Co trimmed its position in shares of CME Group Inc. (NASDAQ:CME) by 4.0% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 31,578 shares of the financial services provider’s stock after selling 1,315 shares during the period. Elo Mutual Pension Insurance Co’s holdings in CME Group were worth $6,208,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Bluefin Capital Management LLC acquired a new position in shares of CME Group in the 4th quarter valued at approximately $2,891,000. Alaska Permanent Fund Corp raised its holdings in CME Group by 81.4% in the first quarter. Alaska Permanent Fund Corp now owns 44,534 shares of the financial services provider’s stock valued at $9,588,000 after acquiring an additional 19,985 shares in the last quarter. Bank of Nova Scotia boosted its stake in CME Group by 229.4% during the 4th quarter. Bank of Nova Scotia now owns 292,597 shares of the financial services provider’s stock valued at $61,618,000 after acquiring an additional 203,769 shares during the last quarter. Oak Harvest Investment Services grew its holdings in CME Group by 66.5% during the 1st quarter. Oak Harvest Investment Services now owns 45,093 shares of the financial services provider’s stock worth $9,708,000 after acquiring an additional 18,017 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC increased its position in shares of CME Group by 21.2% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 48,205 shares of the financial services provider’s stock worth $9,477,000 after purchasing an additional 8,443 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Stock Performance

Shares of NASDAQ CME opened at $216.30 on Thursday. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $223.80. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The company has a market cap of $77.88 billion, a PE ratio of 24.61, a P/E/G ratio of 8.85 and a beta of 0.55. The stock has a 50 day simple moving average of $207.08 and a 200-day simple moving average of $207.54.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. The company had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The company’s quarterly revenue was up 12.7% compared to the same quarter last year. During the same period last year, the company earned $2.30 earnings per share. On average, equities research analysts forecast that CME Group Inc. will post 9.94 EPS for the current year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th will be paid a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.13%. The ex-dividend date is Monday, September 9th. CME Group’s dividend payout ratio is currently 52.33%.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the company. JPMorgan Chase & Co. lifted their price target on CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research note on Thursday, July 25th. Keefe, Bruyette & Woods boosted their price target on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a report on Thursday, July 25th. Piper Sandler reissued an “overweight” rating and set a $225.00 price target on shares of CME Group in a research report on Tuesday, August 20th. Barclays lifted their price objective on shares of CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a report on Thursday, July 25th. Finally, Bank of America downgraded shares of CME Group from a “neutral” rating to an “underperform” rating and reduced their price target for the stock from $212.00 to $177.00 in a research report on Tuesday, September 3rd. Four equities research analysts have rated the stock with a sell rating, five have issued a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $209.73.

Insider Activity

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the sale, the chief financial officer now directly owns 13,261 shares in the company, valued at $2,877,504.39. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. The disclosure for this sale can be found here. Insiders own 0.30% of the company’s stock.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.